loading

Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie

pulisher
Jul 10, 2026

Abeona Therapeutics (NASDAQ: ABEO) shifts 760,870 warrants to SILV Fund - Stock Titan

Jul 10, 2026
pulisher
Jul 10, 2026

Brendan O’Malley sells $83,912 in Abeona Therapeutics stock By Investing.com - Investing.com Australia

Jul 10, 2026
pulisher
Jul 09, 2026

Form 4 Abeona Therapeutics Inc For: 9 July By Investing.com - Investing.com Nigeria

Jul 09, 2026
pulisher
Jul 09, 2026

Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock By Investing.com - Investing.com Nigeria

Jul 09, 2026
pulisher
Jul 09, 2026

Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock By Investing.com - Investing.com Nigeria

Jul 09, 2026
pulisher
Jul 09, 2026

Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock - Investing.com UK

Jul 09, 2026
pulisher
Jul 09, 2026

Abeona (ABEO) CFO sells 24,880 shares to cover taxes on vested stock - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Tax-related stock sale by Abeona (ABEO) CEO leaves 1.31M shares - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Abeona Therapeutics (ABEO) SVP sells shares to cover tax obligations - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Abeona Therapeutics (ABEO) CCO sells 12,606 shares, retains 290,623 - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Form 144 ABEONA THERAPEUTICS INC. For: 9 July By Investing.com - Investing.com South Africa

Jul 09, 2026
pulisher
Jul 09, 2026

ABEO (NASDAQ) Form 144 shows 141,333 restricted shares planned for sale - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Insider share sales and RSAs reported by ABEO (NASDAQ: ABEO) - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

ABEO (NASDAQ: ABEO) director reports proposed stock sales in Form 144 - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

ABEO (Nasdaq: ABEO) files Form 144: 34,230 restricted shares; insider sales noted - Stock Titan

Jul 09, 2026
pulisher
Jul 08, 2026

ABEO Q1 2026 Earnings: Narrowed Loss Surpasses Expectations as Stock Gains 3.82%Earnings Expansion Phase - dars.gov.et

Jul 08, 2026
pulisher
Jul 06, 2026

ABEO (NASDAQ: ABEO) Rule 144 sale notice — 18,160 shares - Stock Titan

Jul 06, 2026
pulisher
Jul 04, 2026

Abeona Therapeutics names Keith Goldan to board of directors - Investing.com

Jul 04, 2026
pulisher
Jul 04, 2026

Price to sales forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView

Jul 04, 2026
pulisher
Jul 02, 2026

Insider Sell Alert: Leila Alland Sells Shares of Abeona Therapeu - GuruFocus

Jul 02, 2026
pulisher
Jul 02, 2026

Abeona Therapeutics (ABEO) director Alland Leila sells 11,000 shares - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

ABEOAbeona Therapeutics Inc Latest SEC Filings - Finviz

Jul 02, 2026
pulisher
Jul 02, 2026

ABEO Should I Buy - Intellectia AI

Jul 02, 2026
pulisher
Jul 01, 2026

Technical Reactions to ABEO Trends in Macro Strategies - Stock Traders Daily

Jul 01, 2026
pulisher
Jul 01, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 01, 2026
pulisher
Jul 01, 2026

Abeona gives 5 new hires restricted stock worth 9,000 shares - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Abeona Therapeutics Inc (ABEO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 01, 2026
pulisher
Jun 29, 2026

Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Abeona Therapeutics Inc.(NasdaqCM: ABEO) added to Russell 2000 Value-Defensive Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 26, 2026

Enterprise value to revenue forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to earnings forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to sales forward of Abeona Therapeutics, Inc. – HAM:PCJ - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Enterprise value to EBITDA forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to earnings forward of Abeona Therapeutics, Inc. – HAM:PCJ - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to EBIT forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to book forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView

Jun 25, 2026
pulisher
Jun 22, 2026

Top Growth Companies With Strong Insider Ownership For June 2026 - simplywall.st

Jun 22, 2026
pulisher
Jun 20, 2026

Trading the Move, Not the Narrative: (ABEO) Edition - Stock Traders Daily

Jun 20, 2026
pulisher
Jun 18, 2026

Abeona Therapeutics Inc (ABEO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics Inc (ABEO) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Abeona Therapeutics (NASDAQ: ABEO) CCO has shares withheld for taxes on RSU vesting - Stock Titan

Jun 17, 2026
pulisher
Jun 16, 2026

Abeona Therapeutics director Christine Silverstein sells $103,695 in stock By Investing.com - Investing.com Australia

Jun 16, 2026
pulisher
Jun 15, 2026

Abeona Therapeutics director Christine Silverstein sells $103,695 in stock - Investing.com

Jun 15, 2026
pulisher
Jun 15, 2026

Abeona Therapeutics (ABEO) director sells 18,160 shares to cover tax - Stock Titan

Jun 15, 2026
pulisher
Jun 15, 2026

[144] ABEONA THERAPEUTICS INC. SEC Filing - Stock Titan

Jun 15, 2026
pulisher
Jun 13, 2026

Abeona Therapeutics Inc. (ABEO) 8-K Filing June 12, 2026: Submission of Matters to a Vote of Security Holders - Minichart

Jun 13, 2026
pulisher
Jun 13, 2026

Abeona Therapeutics announces resignation of board member - The Globe and Mail

Jun 13, 2026
pulisher
Jun 12, 2026

Abeona Therapeutics (ABEO) investors approve equity plan boost, keep director notice rule - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

ABEO: All proposals passed except the advance notice provision amendment for director nominations - TradingView

Jun 12, 2026
pulisher
Jun 12, 2026

Abeona Therapeutics Inc. Announces Resignation of Michael Amoroso as Member of Board of Directors, Nominating and Corporate Governance Committee, Effective June 11, 2026 - marketscreener.com

Jun 12, 2026
pulisher
Jun 12, 2026

Michael Amoroso resigns from Abeona board and nominating committee - TradingView

Jun 12, 2026
pulisher
Jun 12, 2026

Abeona (NASDAQ: ABEO) director Michael Amoroso steps down from board - Stock Titan

Jun 12, 2026
pulisher
Jun 10, 2026

Updated Abeona Therapeutics (NASDAQ: ABEO) investor presentation furnished in 8-K filing - Stock Titan

Jun 10, 2026
$56.43
price down icon 2.64%
$115.61
price down icon 2.24%
$35.97
price down icon 2.28%
$68.27
price down icon 10.83%
ONC ONC
$298.70
price down icon 1.36%
$186.88
price down icon 2.22%
Capitalizzazione:     |  Volume (24 ore):